{
    "Trade/Device Name(s)": [
        "LifeOutcomes C-Quest\u2122 Blood Culture Sampling Device"
    ],
    "Submitter Information": "LifeOutcomes LLC",
    "510(k) Number": "K231282",
    "Predicate Device Reference 510(k) Number(s)": [
        "K192247"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKA"
    ],
    "Summary Letter Date": "January 26, 2024",
    "Summary Letter Received Date": "December 26, 2023",
    "Submission Date": "December 22, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood Specimen Collection Device"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Blood culture contamination"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "Blood culture tube",
        "Standard blood collection syringe"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for LifeOutcomes C-Quest Blood Culture Sampling Device, designed to reduce blood culture contamination through initial specimen diversion.",
    "Indications for Use Summary": "Intended to collect patient blood samples and sequester the first portion to reduce blood culture contamination, used with scalp vein sets for venipuncture or IV extension sets, compatible with blood culture tubes or standard syringes.",
    "fda_folder": "Clinical Chemistry"
}